Service Medical

Dunkerque, France

Service Medical

Dunkerque, France

Time filter

Source Type

Larreche S.,Service Medical | Mion G.,Ecole du Val de Grace | Mayet A.,Service de Sante des Armee | Verret C.,Service de Sante des Armee | And 5 more authors.
American Journal of Emergency Medicine | Year: 2011

Background: Viperidae bites represent a public health issue in Africa and are responsible for a hemorrhagic syndrome with fatal outcome in the short term. A research on Medline database does not reveal any data definitively demonstrating the efficiency of antivenom in case of delayed administration. The aim of this study, based on a 12-year survey of viperine syndromes in Republic of Djibouti, was to compare the normalization of the hemostasis disorders with an early administration of antivenin versus a delayed administration. Methods: A retrospective study was conducted from October 1994 to May 2006 in the intensive care unit of the French military Hospital, in Djibouti. Seventy-three Viperidae-envenomed patients were included. Antivenin efficiency in correcting hemostatic disorders was analyzed in relation to time to treatment (before or after the 24th hour after the bite). Results: Forty-two patients (58%) presented with bleeding. A consumptive coagulopathy was found in 68 patients (93%). Antivenin was observed to be effective in improving hemostasis, and the time to normalization of biologic parameters was similar, whether the treatment was started before or after the 24th hour after the bite. Conclusion: Antivenin should ideally be administered as early as possible. However, in Africa, time to treatment generally exceeds 24 hours. The results of the present evidence-based study confirm an empirical concept: a delayed time to treatment should in no way counterindicate the use of antivenin immunotherapy, in the case of African Viperidae bites. © 2011 Elsevier Inc. All rights reserved.


Mayet A.,Ecole du Val de Grace | Verret C.,Ecole du Val de Grace | Haus-Cheymol R.,Ecole du Val de Grace | Duron S.,Ecole du Val de Grace | And 11 more authors.
European Journal of Clinical Microbiology and Infectious Diseases | Year: 2011

Since the start of 2010 there has been a flare-up of measles in France, following on the resurgence observed in 2008. The aim of this study was to present results of the epidemiological surveillance of measles in the French armed forces and to describe the increase in incidence. Measles was surveyed from 1992 to 2010. Criteria for report were those used for French national compulsory notification. The data, concerning active military personnel, were provided by the physicians in the armed forces using anonymous data collection forms. Between 1992 and July 2010, 689 cases of measles were notified. Since 2002, the mean incidence rate was 1 case per 100,000. A significant increase has been observed for 2010 (13.9 cases per 100,000 in 2010 versus 1.8 in 2009). The 28 cases reported in 2010 involved five clusters and three isolated cases. The mean age of affected subjects was 27 years. Only 30% of cases had been vaccinated. The epidemic resurgence of measles observed in 2010 in the French armed forces follows the same pattern as that observed nationally and at European level, and can be seen as the likely consequence of inadequate vaccination cover. © 2011 Springer-Verlag.


News Article | February 24, 2017
Site: marketersmedia.com

Wiseguyreports.Com Adds “Blood Irradiation -Market Demand, Growth, Opportunities, and analysis of Top Key Player Forecast to 2020” To Its Research Database.Pune, India - February 24, 2017 /MarketersMedia/ — Blood Irradiation Industry Description The players list (Partly, Players you are interested in can also be added) Gamma-Service Medical GmbH Best Theratronics Ltd Rad Source Technologies Asia Limited O3Vets Wenzhou Gengsheng Health Medical Equipment Co., Ltd. Shandong Xinhua Medical Instrument Co., Ltd. Wuhan HNC Technology Co., Ltd. ... With no less than 10 top producers. Request for Sample page @ https://www.wiseguyreports.com/sample-request/556814-global-blood-irradiation-market-professional-survey-report-2016 This report mainly covers the following Product types including Daily home blood irradiation machine Hospital blood irradiation machine Others The segment applications including Home Hospital Others Segment regions including (the separated region report can also be offered) North America Europe Japan China Southeast Asia India Data including (both global and regions): Market Size (both volume - K Units and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc. Report Detail @ https://www.wiseguyreports.com/reports/556814-global-blood-irradiation-market-professional-survey-report-2016 Table of Contents 1 Industry Overview of Blood Irradiation 1.1 Definition and Specifications of Blood Irradiation 1.1.1 Definition of Blood Irradiation 1.1.2 Specifications of Blood Irradiation 1.2 Classification of Blood Irradiation 1.2.1 Daily home blood irradiation machine 1.2.2 Hospital blood irradiation machine 1.2.3 Others 1.3 Applications of Blood Irradiation 1.3.1 Home 1.3.2 Hospital 1.3.3 Others 1.4 Industry Chain Structure of Blood Irradiation 1.5 Industry Overview and Major Regions Status of Blood Irradiation 1.5.1 Industry Overview of Blood Irradiation 1.5.2 Global Major Regions Status of Blood Irradiation 1.6 Industry Policy Analysis of Blood Irradiation 1.7 Industry News Analysis of Blood Irradiation 2 Manufacturing Cost Structure Analysis of Blood Irradiation 2.1 Raw Material Suppliers and Price Analysis of Blood Irradiation 2.2 Equipment Suppliers and Price Analysis of Blood Irradiation 2.3 Labor Cost Analysis of Blood Irradiation 2.4 Other Costs Analysis of Blood Irradiation 2.5 Manufacturing Cost Structure Analysis of Blood Irradiation 2.6 Manufacturing Process Analysis of Blood Irradiation 3 Technical Data and Manufacturing Plants Analysis of Blood Irradiation 3.1 Capacity and Commercial Production Date of Global Blood Irradiation Major Manufacturers in 2015 3.2 Manufacturing Plants Distribution of Global Blood Irradiation Major Manufacturers in 2015 3.3 R&D Status and Technology Source of Global Blood Irradiation Major Manufacturers in 2015 3.4 Raw Materials Sources Analysis of Global Blood Irradiation Major Manufacturers in 2015 4 Global Blood Irradiation Overall Market Overview 4.1 2011-2016E Overall Market Analysis 4.2.1 2011-2015 Global Blood Irradiation Capacity and Growth Rate Analysis 4.2.2 2015 Blood Irradiation Capacity Analysis (Company Segment) 4.3 Sales Analysis 4.3.1 2011-2015 Global Blood Irradiation Sales and Growth Rate Analysis 4.3.2 2015 Blood Irradiation Sales Analysis (Company Segment) 4.4 Sales Price Analysis 4.4.1 2011-2015 Global Blood Irradiation Sales Price 4.4.2 2015 Blood Irradiation Sales Price Analysis (Company Segment) 4.5 Gross Margin Analysis 4.5.1 2011-2015 Global Blood Irradiation Gross Margin 4.5.2 2015 Blood Irradiation Gross Margin Analysis (Company Segment) Continued... Purchase a license copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=556814 For More Information or Any Query Mail at Sales@Wiseguyreports.Com Contact Info:Name: NORAH TRENTEmail: Sales@Wiseguyreports.ComOrganization: WISE GUY RESEARCH CONSULTANTS PVT LTDAddress: Pune -40027, Maharashtra, India Phone: +1-646-845-9349 (US) +44 208 133 9349 (UK)Source URL: http://marketersmedia.com/blood-irradiation-market-2017-global-analysis-opportunities-and-forecast-to-2022/172844For more information, please visit https://www.wiseguyreports.com/sample-request/556814-global-blood-irradiation-market-professional-survey-report-2016Source: MarketersMediaRelease ID: 172844


Ha-Vinh P.,Service Medical | Regnard P.,Service Medical | Huiart L.,French Institute of Health and Medical Research | Sauze L.,Agence Regionale de Sante ARS | Eisinger F.,Institute Paoli Calmettes
Sante Publique | Year: 2015

Aim: When self-employed and small business owners are diagnosed with cancer what is the effect on their small-firm survival duration? Methods: Data Sources: secondary data for 3,587 subjects, 18-65 years, working when diagnosed with cancer in 1995-2009 and a comparison group of 27,688 subjects matched for gender, age and occupation. Study design: a comprehensive population-based longitudinal study. A Cox model described time to failures of small businesses and terminations of self-employment. Data Collection Methods: extraction from the statutory mandatory self-employed social security scheme database. Results: Findings were that age, cancer prognosis and very intense physical workload occupation were independent predictors of enterprise failure for cancer-exposed subjects. Compared with unexposed subjects, their global hazard ratio was 1.59 (95% CI = 1.50-1.70). However, the difference at five years after cancer diagnosis became non-significant: hazard ratio 1.11 (95% CI = 0.95-1.30). Conclusion: These findings demonstrate that beyond 5 years of maintenance of activity, the economic cost of cancer supported by very small businesses and self-employed is not important. However, support is required to pass through these first 5 years. The authors describe the various possible aids that could be implemented. © S.F.S.P.. Tous droits réservés pour tous pays.


ASHLAND, Mass.--(BUSINESS WIRE)--OnProcess Technology, a global pioneer in service supply chain management and optimization, will be a featured moderator at Field Service Medical, taking place February 27 – March 1, 2017, in San Diego, CA. Michael Prokopis, VP Strategy and Innovation for the company, will lead a roundtable on the challenges, benefits and scenarios for using customer data in field service operations. Field Service Medical is an annual gathering of medical device and medical equipment manufacturing executives who want to learn about the latest advances in field mobility, preventative maintenance and predictive analytics. “Medical equipment companies that properly leverage customer data can realize huge improvements in everything from field service SLAs to profitability. However, figuring out how to capture, analyze and provide visibility into the data—let alone turn it into actionable insights—can be very challenging,” said Prokopis. “I look forward to leading a lively discussion on how Field Service Medical attendees are collecting, using and benefiting from customer data, and how they’ve overcome the obstacles they’ve faced.” Prokopis’ roundtable, “Prove It: Use Data to Align Customer Expectations With the Way You Do Business,” is on February 28 at 1:30pm. Conference attendees are also encouraged to visit OnProcess’ booth #5 to learn more about leveraging analytics to enhance medical field service delivery. Visitors can see a demo of OnProcess OPTvisionSM, the only platform that combines real-time, end-to-end visibility with analytics-driven alerts to radically improve post-sales services, including field service operations. About OnProcess Technology OnProcess Technology is a managed services provider specializing in complex, global service supply chain operations – the flow of people, parts and services following the sale of a product. The company’s deep expertise, purpose-built technology delivery and embedded, analytics-based process improvement, enable clients to quickly optimize and scale operations, grow revenue and profitability, and deliver superior customer experiences. OnProcess provides services in 23 languages and operates in six global facilities, including its Massachusetts headquarters and facilities in Maine, Costa Rica, India and Bulgaria. www.onprocess.com


Grondin C.,Service de maternite pediatrie | Duron S.,Center Depidemiologie Et Of Sante Publique Des Armees | Robin F.,Service medical | Verret C.,Center Depidemiologie Et Of Sante Publique Des Armees | Imbert P.,Service de maternite pediatrie
Archives de Pediatrie | Year: 2013

Teenager sexuality is a public health issue. In teenagers attending a high school, we assessed their knowledge and behavior on sexuality, infectious transmitted diseases, human papilloma virus (HPV) vaccination, and cervical cancer. Then in girls, we estimated the anti-HPV vaccination coverage and focused on factors associated with poor knowledge of these topics. Methods: This was a knowledge, attitudes, and practices cross-sectional study conducted at the beginning of the 2010-2011 school year in the Saint-Cyr military high school, using an anonymous self-administered questionnaire. Results: Among 669 adolescents (M/F sex-ratio, 2.3; mean age, 17 years [IC 95%, 15-20]), 40% had already had sex and 92% had used contraception. Boys and girls had a poor level of knowledge on infectious transmitted diseases. Regarding knowledge on HPV and cervical cancer, a better level was significantly associated with female gender (P=10-4). In multivariate analysis, male gender, age under 18 years, lack of dialogue with parents on these subjects, low socioeconomic status of parents, and absence of health education were significantly associated with poor knowledge on these topics. Conclusion: These data should help healthcare providers better target access and content of sexual health education training. © 2013 Elsevier Masson SAS.


Lafon D.,Service Medical | Mathieu-Huart A.,ANSES | Grard O.,ARS Nord Pas de Calais
Archives des Maladies Professionnelles et de l'Environnement | Year: 2012

Human Health Toxicity Values (HHTV) quantify the relationship between exposure to a chemical substance and effects on health. HHTVs are therefore key parameters for making calculations and assessing health risks. Many institutions offer HHTVs in databases on the Internet. Since 2004, France has initiated a process for the development of her own HHTVs. The search and the choice of HHTVs are complex and time-consuming. The French Institute for Public Health Surveillance (InVS) has developed an efficient search engine with free Internet access. Furêtox (facilitating the use of resources in toxicology) is designed to extend the scope and shorten the time of search on the Web. For a given chemical substance, Furêtox can provide swift access to the HHTVs, allow easy access to background documents with details on how the values were established and swift access to carcinogenicity classifications. Furêtox welcomes critical feedback from users and provides references ("fact sheets" for each database) on the methodology used to calculate the values. © 2012 Publié par Elsevier Masson SAS.


Ha-Vinh P.,Service Medical | Randelli P.,Service Medical | Regnard P.,Service Medical
Revue des Maladies Respiratoires | Year: 2013

Introduction.- The aim of this study was to evaluate the evolution from 2006 to 2010 of the prevalence of continuous positive airway pressure treatment for the beneficiaries of two regional health care insurance funds (17 and 43). Methods.- One million forty-eight thousand four hundred and thirty beneficiary-years were analyzed from 2006 to 2010. The prevalence of continuous positive airway pressure treatment was tested with regard to the effect of the year of delivery. A logit regression was used to adjust for potentially confounding differences in age and gender, which were included as covariates. The prevalence of alternative treatments and of controls of reimbursement benefits implemented by the funds are evaluated too during the same period. Results.- Continuous positive airway pressure treatment annual prevalence was 6.34/1000. A significant annual increase of prevalence from 2006 to 2008 was followed by a slowing of the rate of growth starting from 2008. In the same time for fund 43, obesity surgery rose from 41.85/100,000 to 55.44/100,000 and mandibular osteotomy surgery rose from 0.97/100,000 to 4.78/100,000. For fund 17 mandibular advancement devices rose from 10.72/100,000 to 21,08/100,000. The two funds started a reinforced inspections of reimbursement benefits for continuous positive airway pressure treatment in 2008. Conclusions.- The dynamics of continuous positive airway pressure treatment have to be considered in the context of policies introduced and trends in the application of alternative treatments in each fund. © 2012 SPLF. Published by Elsevier Masson SAS. All rights reserved.


Ha-Vinh P.,Service Medical | Regnard P.,Service Medical | Rochas M.,Service Medical | Moncada M.,Service Medical
Diagnostic and Interventional Imaging | Year: 2014

Purpose: The French government plans to install MRI facilities dedicated to musculoskeletal indications. We have analyzed the use of imaging investigations in the community to assess their market share. Materials and methods: We undertook a retrospective analysis of all reimbursements during the year 2012 by the French Social Plan for Independent Workers for 4 imaging methods for a musculoskeletal indication (MRI, CT scan with or without opacification and contrast-enhanced conventional radiography). Results: Three hundred and thirty-two thousand eight hundred and ninety-three beneficiaries were included. The following investigations were used: MRI 12659 investigations; CT scan without direct opacification 7392; CT scan with direct opacification 1271; contrast-enhanced conventional radiography 1187. Of those beneficiaries who underwent investigations of the spine, 39.91% had MRI alone, 8.62% had both MRI and one of the other investigations and 51.46% did not have MRI. The corresponding figures for beneficiaries undergoing lower limb investigations were 79.57%, 4.53% and 15.90% and those for beneficiaries undergoing upper limb investigations were 35.49%, 6.56% and 57.94% respectively. Conclusion: In terms of the numbers of investigations, our results show that in France MRI dedicated to musculoskeletal indications has a wide market share for the spine, upper and lower limbs. © 2014 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.


PubMed | Service medical
Type: Journal Article | Journal: Diagnostic and interventional imaging | Year: 2014

The French government plans to install MRI facilities dedicated to musculoskeletal indications. We have analyzed the use of imaging investigations in the community to assess their market share.We undertook a retrospective analysis of all reimbursements during the year 2012 by the French Social Plan for Independent Workers for 4 imaging methods for a musculoskeletal indication (MRI, CT scan with or without opacification and contrast-enhanced conventional radiography).Three hundred and thirty-two thousand eight hundred and ninety-three beneficiaries were included. The following investigations were used: MRI 12659 investigations; CT scan without direct opacification 7392; CT scan with direct opacification 1271; contrast-enhanced conventional radiography 1187. Of those beneficiaries who underwent investigations of the spine, 39.91% had MRI alone, 8.62% had both MRI and one of the other investigations and 51.46% did not have MRI. The corresponding figures for beneficiaries undergoing lower limb investigations were 79.57%, 4.53% and 15.90% and those for beneficiaries undergoing upper limb investigations were 35.49%, 6.56% and 57.94% respectively.In terms of the numbers of investigations, our results show that in France MRI dedicated to musculoskeletal indications has a wide market share for the spine, upper and lower limbs.

Loading Service Medical collaborators
Loading Service Medical collaborators